Soy phytochemicals decrease nonsmall cell lung cancer growth in female athymic mice

Journal of Nutrition

Volumn 138, Issue 7, 2008, Pages 1360-1364

  Gallo, Daniela ^a   Zannoni, Gian Franco ^a   Stefano, Ilaria De ^a   Mosca, Marco ^a   Ferlini, Cristiano ^a   Mantuano, Elisabetta ^a   Scambia, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE; PLANT EXTRACT; PROTEIN KINASE B; SOMATOMEDIN C; SOYSELECT; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PHYTOESTROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; FEMALE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; NUDE MOUSE; SOYBEAN; TUMOR GROWTH; TUMOR NECROSIS; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; DIET THERAPY; LUNG TUMOR; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; XENOGRAFT;

MUS;

ANIMALS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FEMALE; HUMANS; KI-67 ANTIGEN; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHYTOESTROGENS; PLANT EXTRACTS; RECEPTORS, ESTROGEN; SOYBEANS; TRANSPLANTATION, HETEROLOGOUS;

EID: 46249130551     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/138.7.1360     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Zielinski SL. Diversity in cancer rates, control programs matches diversity of European Union. J Natl Cancer Inst. 2005;97:1398-9.
3. Patel JD, Bach PB, Kris MG. Lung cancer in US women: a contemporary epidemic. JAMA. 2004;291:1763-8.
4. Dubey S, Siegfried JM, Traynor AM, Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond. Lancet Oncol. 2006;7: 416-24.
5. Taioli E, Wynder EL. Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst. 1994;86:869-70.
6. Ganti AK, Sahmoun AE, Panwalkar AW, Tendulkar KK, Potti A. Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol. 2006;24:59-63.
7. Kreuzer M, Gerken M, Heinrich J, Kreienbrock L, Wichmann HE. Hormonal factors and risk of lung cancer among women? Int J Epidemiol. 2003;32:263-71.
8. Schabath MB, Wu X, Vassilopoulou-Sellin R, Vaporciyan AA, Spitz MR. Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res. 2004;10:113-23.
9. Benassayag C, Perrot-Applanat M, Ferre E Phytoestrogens as modulators of steroid action in target cells. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;777:233-48.
10. Magee PJ, Rowland IR. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr. 2004;91:513-31.
11. Sarkar FH, Li Y. Mechanisms of cancer chemoprevention by soy isofkvone genistein. Cancer Metastasis Rev. 2002;21:265-80.
12. Schabath MB, Hernandez LM, Wu X, Pillow PC, Spitz MR. Dietary phytoestrogens and lung cancer risk. JAMA. 2005;294;1493-504.
13. United Kingdom Co-ordinating Committee on Cancer Research. Guidelines for the welfare of animals in experimental neoplasia. 2nd ed. Br J Cancer. 1998;77:1-10.
14. Corbett T, Valeriote F, LoRusso P, Polin L, Panchapor C, Pugh S, White K, Knight J, Demchik L, et al. In vivo methods for screening and preclinical testing. In Teicher BA, editor. Anticancer drug development guide. Totowa (NJ): Humana Press; 1997:75-99.
15. Gallo D, Zannoni GF, Martinelli E, Ferlini C, Fabrizi M, Riva A, Morazzoni P, Bombardelli E, Scambia G. Estradiol and phytoestrogens differently influence the rodent postmenopausal mammary gland. Menopause. 2006;13:72-9.
16. Karamouzis MV, Papavassiliou AG. The IGF-1 network in lung carcinoma therapeutics. Trends Mol Med. 2006;12;595-602.
17. Park SY, Seol DW. Regulation of Akt by EGF-R inhibitors, a possible mechanism of EGF-R inhibitor-enhanced TRAIL-induced apoptosis. Biochem Biophys Res Commun. 2002;295:515-8.
18. Ono M, Kuwano M. Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs. Clin Cancer Res. 2006;12:7242-51.
19. Brognard J, Clark AS, Ni Y, Dennis PA. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res. 2001;61:3986-97.
20. Fang J, Ding M, Yang L, Liu LZ, Jiang BH. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell Signal. 2007;19:2487-97.
21. Xia C, Meng Q, Cao Z, Shi X, Jiang BH. Regulation of angiogenesis and tumor growth by pi 10 alpha and AKT1 via VEGF expression. J Cell Physiol. 2006;209:56-66.
22. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW, Semenza GL. Modulation of Hypoxia-inducible Factor la Expression by the Epidermal Growth Factor/Phosphatidyl-inositol 3-Kinase/PTEN/AKT/FRAP Pathway in Human Prostate Cancer Cells: Implications for Tumor Angiogenesis and Therapeutics. Cancer Res. 2000;60:1541-5.
23. Gallo D, Ferlini C, Fabrizi M, Prislei S, Scambia G. Lack of stimulatory activity of a phytoestrogen-containing soy extract on the growth of breast cancer tumors in mice, Carcinogenesis. 2006;27:1404-9.
24. Ju YH, Fultz J, Allred KF, Doerge DR, Helferich WG. Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinogenesis. 2006;27: 856-63.
25. Morton MS, Arisaka O, Miyake N, Morgan LD, Evans BA. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr. 2002;132:3168-71.
26. Scambia G, Mango D, Signorile PG, Anselmi R, Palena C, Gallo D, Bombardelli E, Morazzoni P, Riva A, et al. Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause. 2000;7:105-11.
27. Stabile LP, Davis ALG, Gubish CT, Hopkins TM, Luketich JD, Christie N, Finkelstein S, Siegfried JM. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor α and β and show biological responses to estrogen. Cancer Res. 2002;62:2141-50.
28. Gallo D, Mantuano E, Fabrizi M, Ferlini C, Mozzetti S, De Stefano I, Scambia G. Effects of a phytoestrogen-containing soy extract on the growth-inhibitory activity of ICI 182,780 in an experimental model of estrogen-dependent breast cancer. Endocr Relat Cancer. 2007;14:317-24.
29. Mai Z, Blackburn GL, Zhou JR. Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice, Carcinogenesis. 2007;28: 1217-23.
30. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr. 1999;129: 1628-35.
31. Singh AV, Franke AA, Blackburn GL, Zhou JR. Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis. Cancer Res. 2006;66:1851-8.